Search results
Results from the WOW.Com Content Network
Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits concerning the legality of cannabis extracts and other products from the hemp plant that have very low or nonexistent natural THC levels, including CBD oil, in the United States. The first is from 2004 and the second is from 2018.
The South Florida Task Force was "the most ambitious drug-interdiction program in the nation's history – all aimed at keeping marijuana out of the country". [7] Under Reagan, in 1985 the DEA began the nation's first non-military public employee mass drug testing program (including testing for THC metabolite). [14]
DEA began the program in 1979 during the War on Drugs. In the first few years of the Reagan administration , the program expanded from seven states to forty. [ 1 ] By 1985 it was active in all fifty states.
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
The proposal is to move marijuana from a Schedule I drug, along with heroin and LSD, to Schedule III, where it would join ketamine and anabolic steroids. ... A formal hearing is set for 9:30 a.m ...
The Associated Press reported Tuesday that the Drug Enforcement Administration will propose moving marijuana from the list of Schedule I drugs, which includes heroin and cocaine, to Schedule III ...
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
A senior official at the US Department of Health and Human Services has called for easing restrictions on marijuana by reclassifying it as a Schedule III substance in a letter to the Drug ...